Developing MYC Degraders Bearing the Von Hippel-Lindau Ligand to Target the "Undruggable" MYC.
开发带有 Von Hippel-Lindau 配体的 MYC 降解剂以靶向“不可成药”的 MYC
期刊:ACS Pharmacology and Translational Science
影响因子:3.7
doi:10.1021/acsptsci.4c00452
Siokatas Christos, Lampropoulou Alexandra, Smina Alexandra, Soupsana Katerina, Kontostathi Martha, Karra Athina-Vasiliki, Karampelas Theodoros, Politou Anastasia S, Christoforidis Savvas, Tamvakopoulos Constantin, Sarli Vasiliki
